We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
176
Clorox
CLX
$12.8B
$3.65M 0.03%
23,751
-1,240
-5% -$185K
DEO icon
177
Diageo
DEO
$49.2B
$3.65M 0.03%
21,644
-58
-0.3% -$9.43K
TTEK icon
178
Tetra Tech
TTEK
$8.78B
$3.54M 0.02%
205,435
+975
+0.5% +$16.9K
ALK icon
179
Alaska Air
ALK
$5.81B
$3.53M 0.02%
52,135
+12,699
+32% +$867K
MA icon
180
Mastercard
MA
$500B
$3.53M 0.02%
11,813
+105
+0.9% +$29.6K
STAG icon
181
STAG Industrial
STAG
$7.19B
$3.52M 0.02%
111,623
-39,221
-26% -$1.2M
MANT
182
DELISTED
Mantech International Corp
MANT
$3.51M 0.02%
43,974
+250
+0.6% +$18.7K
BWXT icon
183
BWX Technologies
BWXT
$15.4B
$3.49M 0.02%
56,173
+820
+1% +$48.7K
MZTI
184
The Marzetti Company
MZTI
$3.05B
$3.49M 0.02%
21,770
+680
+3% +$102K
SON icon
185
Sonoco
SON
$5.78B
$3.48M 0.02%
56,363
+1,739
+3% +$103K
STE icon
186
Steris
STE
$22.7B
$3.47M 0.02%
22,789
-790
-3% -$116K
JNPR
187
DELISTED
Juniper Networks
JNPR
$3.45M 0.02%
140,221
+33,981
+32% +$836K
MLAB icon
188
Mesa Laboratories
MLAB
$574M
$3.37M 0.02%
13,525
+60
+0.4% +$14.1K
CMD
189
DELISTED
Cantel Medical Corporation
CMD
$3.29M 0.02%
46,401
-1,472
-3% -$107K
NNN icon
190
NNN REIT
NNN
$9.01B
$3.23M 0.02%
60,291
+3,228
+6% +$179K
COST icon
191
Costco
COST
$418B
$3.21M 0.02%
10,921
+1,221
+13% +$363K
PM icon
192
Philip Morris
PM
$294B
$3.17M 0.02%
37,246
-6,543
-15% -$539K
KMB icon
193
Kimberly-Clark
KMB
$37.3B
$3.13M 0.02%
22,757
+910
+4% +$123K
EOG icon
194
EOG Resources
EOG
$71.5B
$3.09M 0.02%
36,918
-11,845
-24% -$868K
SLP icon
195
Simulations Plus
SLP
$371M
$3.08M 0.02%
105,874
-172
-0.2% -$5.83K
VAC icon
196
Marriott Vacations Worldwide
VAC
$3.49B
$3.06M 0.02%
23,747
+126
+0.5% +$14.8K
OPLN
197
Openlane
OPLN
$4.05B
$2.96M 0.02%
135,979
+2,287
+2% +$52.1K
IEFA icon
198
iShares Core MSCI EAFE ETF
IEFA
$194B
$2.95M 0.02%
45,173
+470
+1% +$29.8K
ATR icon
199
AptarGroup
ATR
$8.69B
$2.92M 0.02%
25,277
BBSI icon
200
Barrett Business Services
BBSI
$985M
$2.9M 0.02%
128,280
+416
+0.3% +$9.22K

Similar funds

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.